The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 32.10

Age-Adjusted SEER Incidencea , by Year and Sex

By Adapted Classification Scheme for Tumors of Adolescents and Young Adultsb

All Races, Ages 30-34

Both Sexes
Site 1975-2011 2002-2011
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 62,104 85.1 0.9* 17,850 91.0 1.1*
1. Leukemias 2,066 2.8 0.5* 609 3.1 0.5*
2. Lymphomas 6,826 9.4 1.6* 1,872 9.5 1.0
3. CNS, intracranial, intraspinal 2,458 3.4 0.4 700 3.6 0.4
4. Osseous & chondromatous neoplasms 462 0.6 0.6 134 0.7 0.6
5. Soft tissue sarcomas 5,037 6.9 1.3 737 3.8 -1.0
6. Germ cell and trophoblastic neoplasms 5,157 7.1 1.8* 1,580 8.1 0.5
7. Melanoma and skin carcinomas 7,922 10.9 1.6* 2,339 11.9 -0.1
8. Carcinomas (excluding skin) 31,200 42.8 0.6* 9,547 48.6 1.9*
9. Miscellaneous specified neoplasms, NOS 669 0.9 1.9* 238 1.2 1.9*
10. Unspecified malignant neoplasms 306 0.4 1.0 93 0.5 1.0
Males
Site 1975-2011 2002-2011
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 25,804 70.7 0.9* 6,790 68.9 0.9*
1. Leukemias 1,205 3.3 0.8* 352 3.6 0.8*
2. Lymphomas 4,239 11.6 1.2 1,063 10.8 1.8
3. CNS, intracranial, intraspinal 1,430 3.9 0.2 403 4.1 0.2
4. Osseous & chondromatous neoplasms 254 0.7 0.4 69 0.7 0.4
5. Soft tissue sarcomas 4,059 11.1 1.2 457 4.6 -2.8*
6. Germ cell and trophoblastic neoplasms 4,821 13.2 1.8* 1,488 15.1 0.5
7. Melanoma and skin carcinomas 3,180 8.7 0.1 890 9.0 0.1
8. Carcinomas (excluding skin) 6,247 17.1 0.6* 1,935 19.6 2.5*
9. Miscellaneous specified neoplasms, NOS 262 0.7 2.4* 103 1.0 2.4*
10. Unspecified malignant neoplasms 107 0.3 - 30 0.3 -
Females
Site 1975-2011 2002-2011
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 36,300 99.5 0.7* 11,060 113.2 1.5*
1. Leukemias 861 2.4 0.1 257 2.6 0.1
2. Lymphomas 2,587 7.1 1.3* 809 8.3 1.3*
3. CNS, intracranial, intraspinal 1,028 2.8 0.5 297 3.0 0.5
4. Osseous & chondromatous neoplasms 208 0.6 - 65 0.7 -
5. Soft tissue sarcomas 978 2.7 0.4 280 2.9 0.4
6. Germ cell and trophoblastic neoplasms 336 0.9 0.2 92 0.9 0.2
7. Melanoma and skin carcinomas 4,742 13.0 2.2* 1,449 14.8 1.0*
8. Carcinomas (excluding skin) 24,953 68.4 0.6* 7,612 77.9 1.7*
9. Miscellaneous specified neoplasms, NOS 407 1.1 1.7* 135 1.4 1.7*
10. Unspecified malignant neoplasms 199 0.5 - 63 0.6 -

Footnotes:

Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Rates are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b Adapted from: RD Barr, EJ Holowaty, JM Birch. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer. 106:7; 1425-1430. (Restricted to malignant tumors and updated based on ICD-O-3 definitions).

c The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2011.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.